Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has been selected for addition to the NASDAQ Biotechnology Index .
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131219005181&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131219005181&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment